Search Results

You are looking at 1 - 2 of 2 items for

  • Author or Editor: Lin Wang x
  • Refine by Content Type: All x
Clear All Modify Search
Lin Wang and Eugene Lin

The flurry of kidney-related policies continues unabated, and 2022 brings to the fore another set of policy challenges and opportunities (Figure 1).

Policies to Watch in 2022

A new eGFR equation

In 2020, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) established a joint task force aimed at addressing the use of race in the estimated glomerular filtration rate (eGFR). In a highly anticipated recommendation, the task force published alternatives to using race, a social construct, in eGFR. The task force also tackled challenges for the nephrology community moving forward (1

Arshia Ghaffari, Quinn Lougheide, and Lin Wang

As nephrologists, we are perpetually searching for more time in our workdays. Oftentimes, we find ourselves juggling among inpatient, clinic, dialysis unit, and administrative duties, all within the same day. This begs the question: Can nephrologists be more efficient while still providing high-quality patient-centered care?

In the current fee-for-service Medicare payment model, dialysis patients are mandated to have a comprehensive nephrologist evaluation at least once monthly (1). Hemodialysis (HD) patients can be seen up to an additional three times with increasing levels of reimbursement. This encourages an increased number of visits, irrespective of medical necessity. While some have